Overview ( 4,700 members taking Adalimumab )
This product is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, anklyosing spondylitis, Crohn's disease, ulcerative colitis, and psoriasis. It binds to tumor necrosis factor (TNF) to decrease inflammatory and immune responses.
This product has a black box warning relating to an increased risk of serious and potentially fatal infections, including tuberculosis. This product also has a black box warning relating to an increased risk of Lymphoma and other cancers when used in children and adolescents.
What is your Risk Rating for this medicine?
The risk of serious side effects for taking this medicine can be different if you take other medicines or if you suffer from a condition. Get your Risk Rating by creating a profile in a few steps.
- We monitor your health and alert you to any safety updates and recalls.
- You get to talk directly to other members about their experience.
- You can create profiles for you and your loved ones.
We check for possible drug-drug or drug-condition interactions for your medical treatment so you know when there is an issue. Drug interactions may create serious side effects that you want to discuss with your doctor.Register to check interactions